Search results
Imunon Inc (IMNN) Q1 2024 Earnings Call Transcript Highlights: S
Guru Focus· 34 minutes agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Imunon Inc (IMNN, Financial) has initiated enrollment in a Phase ...
Biophytis Announces the Design of its Phase 2 OBA Clinical Study in Obesity
Benzinga· 2 hours agoPARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / May 14, 2024 / Biophytis SA ALBPS, ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the ...
Vaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...
GuruFocus.com via Yahoo Finance· 23 minutes agoPositive Points Vaxart Inc (NASDAQ:VXRT) reported positive results from the Phase 1 clinical trial of its oral pill ...
Clinical trial: New drug makes exercise, everyday tasks easier for people with common heart...
Medical Xpress· 7 hours agoPeople with a common heart condition were able to use significantly more oxygen while exercising...
Replicate Bioscience Presents Positive Data from Phase 1 Trial and Preclinical Data with Novel...
KOIN News 6 Portland· 3 days ago"At ASGCT, Replicate is presenting two important breakthroughs in srRNA...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 9 hours agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Cardurion’s PDE9 inhibitor increases cGMP in Phase IIa heart failure trial
Clinical Trials Arena via Yahoo Finance· 22 hours agoCardurion Pharmaceuticals has said its phosphodiesterase-9 (PDE9) inhibitor, CRD-740, has met the...
Clinical trial investigating aficamten meets primary endpoint in obstructive hypertrophic...
Medical Xpress· 12 hours agoEven though mortality and hospitalization rates have improved, the quality of life for those living...
Capricor Therapeutics Inc (CAPR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
GuruFocus.com via Yahoo Finance· 26 minutes agoPositive Points Completed enrollment for Cohort A in the HOPE three Phase three pivotal trial, with positive interim analysis indicating potential efficacy ...
Fulcrum Therapeutics Inc (FULC) Q1 2024 Earnings Call Transcript
Guru Focus· 34 minutes agoCash, Cash Equivalents, and Marketable Securities: $213.3 million as of March 31, 2024, down from $236.2 million as of December 31, 2023.Pro Forma Cash Positio